Development of a Human Preclinical Platform for the Identification of Neuroprotective Compounds.

Eur J Neurosci · 2025 · PMC12641211 · PMID 41277173

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

All three compounds also showed a trend to reduce the number of activated caspase‐3+ neurons; however, only following IL‐4 and pioglitazone treatment did the effect reach significance compared to vehicle (Figure 1L–M ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.